 | Up a level |
2019
Schwermer, M., Hiber, M., Dreesmann, S., Rieb, A., Theissen, J., Herold, T., Schramm, A., Temming, P. and Steenpass, L. (2019). Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines. Exp. Cell Res., 375 (2). S. 92 - 100. SAN DIEGO: ELSEVIER INC. ISSN 1090-2422
2018
Ackermann, S., Cartolano, M., Hero, B., Roderwieser, A., Bartenhagen, C., Rosswog, C., Hertwig, F., Simon, T., Eggert, A., Speleman, F., Buettner, R., O'Sullivan, R., Thomas, R., Berthold, F., Vandesompele, J., Schramm, A., Westermann, F., Schulte, J., Peifer, M. and Fischer, M. (2018). A Mechanistic Classification of Clinical Phenotypes in Neuroblastoma. Pediatr. Blood Cancer, 65. S. S87 - 2. HOBOKEN: WILEY. ISSN 1545-5017
Ackermann, S., Cartolano, M., Hero, B., Roderwieser, A., Bartenhagen, C., Rosswog, C., Hertwig, F., Simon, T., Eggert, A., Speleman, F., Buettner, R., O'sullivan, R., Thomas, R., Berthold, F., Vandesompele, J., Schramm, A., Westermann, F., Schulte, J., Peifer, M. and Fischer, M. (2018). A Mechanistic Classification of Clinical Phenotypes in Neuroblastoma. Pediatr. Blood Cancer, 65. S. S234 - 1. HOBOKEN: WILEY. ISSN 1545-5017
2016
Peifer, M., Hertwig, F., Roels, F., Dreidax, D., Gartlgruber, M., Menon, R., Hero, B., Schramm, A., Schulte, J. H., Herrmann, C., O'Sullivan, R. J., Westermann, F., Thomas, R. K. and Fischer, M. (2016). Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Oncol. Res. Treat., 39. S. 43 - 44. BASEL: KARGER. ISSN 2296-5262
Schulte, J., Schramm, A., Koester, J., Westermann, F., Peifer, M., Fischer, M., Rahmann, S. and Eggert, A. (2016). Mutational dynamics between primary and relapse neuroblastoma involve genes relevant for mesenchymal transition. Oncol. Res. Treat., 39. S. 30 - 32. BASEL: KARGER. ISSN 2296-5262
2015
Eggert, A., Schramm, A., Koester, J., Assenov, Y., Kristina, A., Engesser, A., Kahlert, Y., Theissen, J., Hero, B., Roels, F., Peifer, M., Astrahantseff, K., Depreter, K., Lode, H., Speleman, F., Schmezer, P., Westermann, F., Rahmann, S., Fischer, M. and Schulte, J. (2015). INTEGRATED GENOMIC ANALYSIS IDENTIFIES SPECIFIC ALTERATIONS AND ACTIVATION OF YAP IN RELAPSED NEUROBLASTOMA. Pediatr. Blood Cancer, 62. S. S145 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
Peifer, M., Roels, F., Hertwig, F., Menon, R., Kraemer, A., Buettner, R., Perner, S., Schramm, A., Schulte, J. H., Hero, B., O'Sullivan, R. J., Westermann, F., Thomas, R. K. and Fischer, M. (2015). TELOMERASE ACTIVATION BY RECURRENT GENOMIC REARRANGEMENTS IN HIGH-RISK NEUROBLASTOMA. Pediatr. Blood Cancer, 62. S. S149 - 2. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
2013
Schulte, J. H., Schulte, S., Heukamp, L. C., Astrahantseff, K., Stephan, H., Fischer, M., Schramm, A. and Eggert, A. (2013). Targeted Therapy for Neuroblastoma: ALK Inhibitors. Klinische Padiatr., 225 (6). S. 303 - 309. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3824